4
NEW YORK, Aug 10 (Reuters) – Hims & Hers Health on Monday posted a bigger-than-expected second-quarter loss as the telehealth company's shift to branded weight-loss drugs drove up costs. Shares of the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)